Related Experiment Videos
Hepatic ischemia-reperfusion injury
F Serracino-Inglott1, N A Habib, R T Mathie
1Division of Surgery, Anaesthetics, and Intensive Care, Imperial College School of Medicine, Hammersmith Hospital, London, United Kingdom.
American Journal of Surgery
|June 27, 2001
Summary
Ischemia-reperfusion injury contributes to liver surgery complications. Targeting mediators like endothelin and nitric oxide imbalance can improve outcomes in liver transplantation and resection.
Area of Science:
- Hepatology
- Transplantation Surgery
- Immunology
Background:
- Liver transplantation and major hepatic resections carry significant morbidity.
- Ischemia-reperfusion injury is a key contributor to this morbidity.
Purpose of the Study:
- To review the literature on hepatic ischemia-reperfusion injury.
- To identify key mediators and potential therapeutic targets.
Main Methods:
- Comprehensive literature search of Medline.
- Keywords included reperfusion injury, liver transplantation, liver resection, nitric oxide, endothelin, cytokines, Kupffer cells, ischemic preconditioning, and nuclear factor-kappa B.
Main Results:
- An imbalance between endothelin and nitric oxide disrupts hepatic microcirculation during reperfusion.
- Nuclear factor-kappa B activation promotes pro-inflammatory responses and cellular injury.
- Therapeutic strategies targeting these mediators show promise in animal models.
Conclusions:
- Hepatic microcirculation failure during reperfusion is linked to endothelin/nitric oxide imbalance.
- Nuclear factor-kappa B activation exacerbates injury through cytokine and adhesion molecule synthesis.
- Translating findings from animal models to clinical practice can enhance outcomes in hepatic surgery.